Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Carboplatin for Localized, High Risk Prostate Cancer With Germline BRCA1/2 Mutations
NCT05806515Phase 2Recruiting
- Sponsor
- SWOG Cancer Research Network
- Start
- Mar 2024
- Primary completion
- Jul 2027
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin in prostate adenocarcinoma, sponsored by SWOG Cancer Research Network. Started Mar 2024; status: recruiting.
02
Drugs
carboplatin
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT05806515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05806515.